Receipt of colorectal testing prior to colorectal carcinoma diagnosis - A population-based study

被引:13
作者
Cooper, GS
Payes, JD
机构
[1] Univ Hosp Cleveland, Div Gastroenterol, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Ctr Comprehens Canc, Cleveland, OH 44106 USA
关键词
colorectal neoplasms; screening; colonoscopy; sigmoidoscopy; fecal occult blood testing; barium enema; Medicare;
D O I
10.1002/cncr.20839
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. Among patients with established colorectal carcinoma, the prior use of procedures for colorectal carcinoma screening is unknown. In addition, the association of disease stage at the time of diagnosis with previous procedure use has not been studied previously at a population level. METHODS. The Surveillance, Epidemiology, and End Results tumor registry files identified 5806 patients age greater than or equal to 70 years with an initial colorectal carcinoma diagnosis in 1999. Medicare claims data from 1995 through diagnosis were extracted and identified receipt of fecal occult blood testing (FOBT), sigmoidoscopy, colonoscopy, and barium enema. Time intervals were divided into > 6 months prior to diagnosis and less than or equal to 6 months of diagnosis as probable screening versus diagnostic indications, respectively. RESULTS. The most commonly performed procedure was colonoscopy (63%), but most colonoscopic examinations were within 6 months of diagnosis. Only 44% of patients received greater than or equal to 1 procedures > 6 months before diagnosis, with FOBT the most frequent procedure (36%). Colonoscopy was performed in only 6% of patients prior to the 6-month peridiagnostic period. Compared with patients who underwent no procedures or who underwent procedures only within 6 months of diagnosis, those who underwent procedures > 6 months earlier presented with earlier stages of carcinoma. CONCLUSIONS, The receipt of colorectal procedures in the interval > 6 months pricy to a diagnosis of colorectal carcinoma was low, suggesting the under use of screening in this population. The association of procedure use with earlier stage at presentation as well as unmeasured benefits in reducing carcinoma incidence suggest beneficial effects of this testing. (C) 2005 American Cancer Society.
引用
收藏
页码:696 / 701
页数:6
相关论文
共 24 条
[1]   Screening for colorectal cancer: Recommendation and rationale [J].
Berg, AO ;
Allan, JD ;
Frame, PS ;
Homer, CJ ;
Johnson, MS ;
Klein, JD ;
Lieu, TA ;
Mulrow, CD ;
Orleans, CT ;
Peipert, JF ;
Pender, NJ ;
Siu, AL ;
Teutsch, SM ;
Westhoff, C ;
Woolf, SH .
ANNALS OF INTERNAL MEDICINE, 2002, 137 (02) :129-131
[2]   TEMPORAL PATTERNS IN COLORECTAL-CANCER INCIDENCE, SURVIVAL, AND MORTALITY FROM 1950 THROUGH 1990 [J].
CHU, KC ;
TARONE, RE ;
CHOW, WH ;
HANKEY, BF ;
RIES, LAG .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (13) :997-1006
[3]   The accuracy of diagnosis and procedural codes for patients with upper GI hemorrhage [J].
Cooper, GS ;
Chak, A ;
Lloyd, LE ;
Yurchick, PJ ;
Harper, DL ;
Rosenthal, GE .
GASTROINTESTINAL ENDOSCOPY, 2000, 51 (04) :423-426
[4]  
*CTR DIS CONTR PRE, 2003, MMWR-MORBID MORTAL W, V52, P193
[5]   THE ACCURACY OF MEDICARES HOSPITAL CLAIMS DATA - PROGRESS HAS BEEN MADE, BUT PROBLEMS REMAIN [J].
FISHER, ES ;
WHALEY, FS ;
KRUSHAT, WM ;
MALENKA, DJ ;
FLEMING, C ;
BARON, JA ;
HSIA, DC .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1992, 82 (02) :243-248
[6]   Randomised controlled trial of faecal-occult-blood screening for colorectal cancer [J].
Hardcastle, JD ;
Chamberlain, JO ;
Robinson, MHE ;
Moss, SM ;
Amar, SS ;
Balfour, TW ;
James, PD ;
Mangham, CM .
LANCET, 1996, 348 (9040) :1472-1477
[7]  
IEZZONI LI, 1994, RISK ADJUSTMENT MEAS, P119
[8]   Cancer statistics, 2004 [J].
Jemal, A ;
Tiwari, RC ;
Murray, T ;
Ghafoor, A ;
Samuels, A ;
Ward, E ;
Feuer, EJ ;
Thun, MJ .
CA-A CANCER JOURNAL FOR CLINICIANS, 2004, 54 (01) :8-29
[9]   Randomised study of screening for colorectal cancer with faecal-occult-blood test [J].
Kronborg, O ;
Fenger, C ;
Olsen, J ;
Jorgensen, OD ;
Sondergaard, O .
LANCET, 1996, 348 (9040) :1467-1471
[10]   The effect of fecal occult-blood screening on the incidence of colorectal cancer [J].
Mandel, JS ;
Church, TR ;
Bond, JH ;
Ederer, F ;
Geisser, MS ;
Mongin, SJ ;
Snover, DC ;
Schuman, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (22) :1603-1607